| Literature DB >> 28834038 |
Hiwa K Saeed1, Paul J Jarman1, Stuart Archer1, Sreejesh Sreedharan1, Ibrahim Q Saeed2, Luke K Mckenzie1, Julia A Weinstein1, Niklaas J Buurma2, Carl G W Smythe3, Jim A Thomas1.
Abstract
Using a new mononuclear "building block," for the first time, a dinuclear RuII (dppn) complex and a heteroleptic system containing both RuII (dppz) and RuII (dppn) moieties are reported. The complexes, including the mixed dppz/dppn system, are 1 O2 sensitizers. However, unlike the homoleptic dppn systems, the mixed dppz/dppn complex also displays a luminescence "switch on" DNA light-switch effect. In both cisplatin sensitive and resistant human ovarian carcinoma lines the dinuclear complexes show enhanced uptake compared to their mononuclear analogue. Thanks to a favorable combination of singlet oxygen generation and cellular uptake properties all three of the new complexes are phototoxic and display potent activity against chemotherapeutically resistant cells.Entities:
Keywords: luminescence; metallo-intercalators; photodynamic therapy; ruthenium(II); singlet oxygen
Mesh:
Substances:
Year: 2017 PMID: 28834038 DOI: 10.1002/anie.201707350
Source DB: PubMed Journal: Angew Chem Int Ed Engl ISSN: 1433-7851 Impact factor: 15.336